Thyroid Cancer Treatment

Hospitalization: Yes Length of Stays: 0 ~ 0days

Appointment: Yes

Price: Price must be evaluated by physicians Foreign Exchange Rate(The information is indicative only)

Payments: Cach, Credit Card, Wire Transfer

Treatment introduction
Thyroid nodules are present in 5-10% of women and 1% of men. Its prevalence by ultrasound is 19-67%. Most nodules are benign (85-95%). Most are nonfunctional but may cause compression to surround organs if bigger than 2-4 cm. The risk of malignancy in is the same whether there is one nodule or multiple nodules. Genes Mutations are often responsible for malignant transformation of thyroid follicular cells (eg, RET, TRK, RAS, BRAF, p53, etc.). Risk factors including Head and neck external beam radiation therapy, particularly during childhood; Exposure to nuclear explosion or fallout; History of thyroid cancer in a first-degree relative. Family history of a syndrome associated with thyroid cancer; In areas of iodine deficiency. DTC is generally detected by palpation or neck ultrasound, esp. with malignancy features: hypoechogenicity, microcalcifications, irregular borders, increased vascularity etc. Fine needle aspiration (FNA) cytology often exam the nodules more than 1 cm. If FNA cytology is suggestive of a papillary thyroid cancer or a follicular neoplasm, surgery is recommended for pathology proven. Distinguishing FTC from a benign follicular adenoma requires identification of vascular invasion or tumor extension through the tumor capsule. Surgery is the primary therapy for DTC, and the procedure is bilateral total thyroidectomy. If tumor size < 1 cm and confined to one lobe, unilateral lobectomy can be considered. Regional neck dissection if evidence of nodal involvement on exam or preoperative ultrasound. Prophylactic central neck dissection is highly suggestive in patents with advanced papillary cancer (T3 or T4) even in the absence of clinical evidence of nodal involvement. Radioactive iodine (RAI) ablation therapy (30-200mCi; most 30-120 mCi) often performed followed by posttreatment whole bosy scan. RAI can destroying persist thyroid cancer calls and the scan can identify distant metastases. RAI ablation may not performed for tumor < 4 cm without evidence of local invasion, lymph node metastasis, or distal metastasis. RAI ablation should be performed under TSH > 30 uIU/ml and the patient should eat low iodine diet at least 2-4 weeks.
Remarks
Please be advised that patient must consult with medical professionals before initiating treatment services. Actual treatment planning is on a case-by-case basis.